RxDoctor Payments Data

Vernon Forrester, MD

MOHS-Micrographic Surgery · Madison, ALNPI 1679002729

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 163 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations.

$3,653in general payments, 2019–2025

Across 163 payments — averaging $22.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$750
  • AbbVie$510
  • Novartis$447
  • Johnson & Johnson$396
  • Sanofi$266
  • Kerecis Limited$169
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$3,653100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few mohs-micrographic surgery providers in Alabamato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$1,065,057
Medicare patients
617
Services billed
3,475

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gentamicin Sulfate80$3,473
Clobetasol Propionate46$2,998
Fluorouracil29$2,310
Triamcinolone Acetonide115$1,731
Doxycycline Hyclate105$1,694
Ketoconazole72$1,255
Selenium Sulfide113$1,225
Fluocinonide31$1,154
Metronidazole11$1,070
Clindamycin Phosphate16$752
Mupirocin83$732
Cephalexin100$558
Ammonium Lactate21$492
Minoxidil34$342
Fluconazole22$117

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Madison

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →